metformin hydrochloride tablet, extended release
inventia healthcare private limited - metformin hydrochloride (unii: 786z46389e) (metformin - unii:9100l32l2n) - metformin hydrochloride 500 mg - metformin hydrochloride extended release tablets usp are indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. metformin hydrochloride are contraindicated in patients with: - renal disease or renal dysfunction (e.g., as suggested by serum creatinine levels ≥1.5 mg/dl [males], ≥1.4 mg/dl [females] or abnormal creatinine clearance) which may also result from conditions such as cardiovascular collapse (shock), acute myocardial infarction, and septicemia (see warnings and precautions ). - known hypersensitivity to metformin hydrochloride. - acute or chronic metabolic acidosis, including diabetic ketoacidosis, with or without coma. diabetic ketoacidosis should be treated with insulin. metformin hydrochloride should be temporarily discontinued in patients undergoing radiologic studies involving intravascular administration of iodinated contrast materials, because use of such products may result in acute alteration of renal function. (see also precautions.
amiloride 5mg tablets
a a h pharmaceuticals ltd - amiloride hydrochloride - oral tablet - 5mg
amiloride 5mg tablets
actavis uk ltd - amiloride hydrochloride - oral tablet - 5mg
amiloride 5mg tablets
teva uk ltd - amiloride hydrochloride - oral tablet - 5mg
amiloride 5mg tablets
the boots company plc - amiloride hydrochloride - oral tablet - 5mg
amiloride 5mg tablets
wockhardt uk ltd - amiloride hydrochloride - oral tablet - 5mg
amiloride 5mg tablets
viatris uk healthcare ltd - amiloride hydrochloride - oral tablet - 5mg
amiloride 5mg tablets
kent pharma (uk) ltd - amiloride hydrochloride - oral tablet - 5mg
amiloride 5mg tablets
alliance healthcare (distribution) ltd - amiloride hydrochloride - oral tablet - 5mg
amiloride 5mg tablets
sun pharma uk ltd - amiloride hydrochloride - oral tablet - 5mg